8 August 2016 Blog No exclusivity for data generated to support a hybrid-abridged application Alongside patent protection, data exclusivity can offer valuable market protection to a pharmaceutical product. But can data in support of a product approved through the so-called hybrid-abridged procedure attract the same kind of protection? The High Court says they can’t... Share this article Bookmark this page 3 min read
26 May 2016 Blog Pfizer's win in meningitis B vaccine dispute does not take GSK's Bexsero off the market A recent patent dispute between GlaxoSmithKline and Pfizer group company Wyeth did not follow the usual pattern of an injunction against the infringer's product despite a win for the patentee. Share this article Bookmark this page 3 min read
3 April 2016 Blog Tough treatment for an innovative proposal - what happened to the Saatchi Bill? Following the tragic death of Lord Saatchi’s wife from ovarian cancer in 2011 and a two-year campaign, it was only after a surprise veto by the Liberal Democrats that the Bill was defeated... Share this article Bookmark this page 2 min read